Geneva, June 20 -- International Clinical Trials Registry received information related to the study (ISRCTN45436103) titled 'Physiological study of kisspeptin in post-menopausal health' on June 16.
Study Type: Interventional
Study Design:
Randomized double-blind placebo-controlled study (Other)
Primary Sponsor: Imperial College London
Condition:
Post-menopausal women who are at a higher risk of conditions affecting the liver, bone and brain.
Nutritional, Metabolic, Endocrine
Intervention:
The eligible participants will be first invited to the screening visit. If they agree to join the study, they will be randomly assigned to give themselves subcutaneous (under the skin) injections of either kisspeptin 12.8nmol/kg, or placebo (...